1 / 22

Pulmonary tuberculosis

Pulmonary tuberculosis. DR. Yousef Noaimat MD.FCCP Consultant in pulmonary and internal medicine. History. Tubercular decay has been found in the spines of Egyptian mummies . Pictured: Egyptian mummy in the British Museum. Epidemiology.

shanta
Download Presentation

Pulmonary tuberculosis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pulmonary tuberculosis DR. Yousef Noaimat MD.FCCP Consultant in pulmonary and internal medicine.

  2. History • Tubercular decay has been found in the spines of Egyptianmummies. • Pictured: Egyptian mummy in the British Museum

  3. Epidemiology • According to the World Health Organization (WHO), nearly 2 billion people—one third of the world's population—have been exposed to the tuberculosis pathogen • Annually, 8 million people become ill with tuberculosis, and 2 million people die from the disease worldwide

  4. World TB incidence. Cases per 100,000; Red => 300, orange = 200–300, yellow = 100–200, green = 50–100, blue =< 50 and grey = n/a. Data fromWHO, 2006

  5. Reason for increase incidence • HIV infections and the neglect of TB control programs • drug-resistant : from 2000 to 2004, 20% of TB cases being resistant to standard treatments and 2% resistant to second-line drugs • Lack of access to health care • Poverty

  6. Definition:Pulmonary tuberculosis (TB) is a contagious bacterial infection that mainly involves the lungs, but may spread to other organs caused by the Mycobacterium tuberculosis and Mycobacterium bovis • In the United States, most people will recover from primary TB infection without further evidence of the disease. The infection may stay non active for years and then reactivate. • Most people who develop symptoms of a TB infection first became infected in the past. However, in some cases, the disease may become active within weeks after the primary infection

  7. Transmission • cough, sneeze, speak, they expel infectious aerosol droplets 0.5 to 5 µm in diameter. A single sneeze can release up to 40,000 droplets.Each one of these droplets may transmit the disease, since the infectious dose of tuberculosis is very low and the inhalation of just a single bacterium can cause a new infection • Transmission can only occur from people with active — not latent 

  8. When the disease becomes active, 75% of the cases arepulmonaryTB • the other 25% of active cases, the infection moves from the lungs, causing other kinds of TB

  9. Clinical presentation The primary stage of the disease usually doesn't have symptoms. When symptoms do occur, they may include: • Cough heamoptysis • Excessive sweating, especially at night • Fatigue • Fever • Unintentional weight loss Other symptoms that may occur with this disease: • Breathing difficulty • Chest pain • Wheezing

  10. Examination • Examination may show: • Clubbing of the fingers or toes (in people with advanced disease) • Enlarged or tender lymph nodes in the neck or other areas • Fluid around a lung • Unusual breath sounds (crackles)

  11. Diagnosis • Sputum examination and cultures(ZN STAIN) how can I take a good sample? • Chest x-ray • Chest CT scan • Bronchoscopy • tuberculin skin test • Gastric aspiration? • The main problem with tuberculosis diagnosis is the difficulty in culturing this slow-growing organism in the laboratory (it may take 4 to 12 weeks for blood or sputum culture

  12. Mantoux tuberculin skin test

  13. polymerase chain reactiondetection of bacterial DNA, and assays to detect the release ofinterferon gammain response to mycobacterial proteins such as ESAT These are not affected by immunization orenvironmental mycobacteria, so generate fewerfalse positiveresults

  14. Treatment • Latent TB treatment usually uses a single antibiotic • People with latent infections are treated to prevent them from progressing to active TB disease later in life. However, treatment using Rifampicin and Pyrazinamide is not risk-free. The Centers for Disease Control and Prevention (CDC) notified healthcare professionals of revised recommendations against the use of rifampin plus pyrazinamide for treatment of latent tuberculosis infection, due to high rates of hospitalization and death from liver injury associated with the combined use of these drugs

  15. Treatment • while active TB disease is best treated with combinations of several antibiotics, to reduce the risk of the bacteria developing antibiotic resistance • The two antibiotics most commonly used are rifampicin and isoniazid

  16. Treatment • Initial phase 8 WKS: • rifampicin +isoniazid +PYRAZINAMIDE • If resistant possible add ethmbutol or sterptomycin • Give pyridoxine throughout treatment • Continuation phase (4month) • rifampicin +isoniazid+ pyridoxine

  17. Treatment When can I say treatment failure?

  18. Treatment failure is defined by • + culture after 3 months • +AFB stain after 5 months • And should be treated by adding 2 more drug

  19. Treatment • Main side effect • Rifampicin: hepatitis (small raise of ASTis acceptable . Stop if biliurubin raise) • Isoniazid: hepatitis. Neuropathy • ethmbutol: optic neuropathy • PYRAZINAMIDE: hepatitis (contraindicted in gout)

  20. Prevention • identified people with TB and their contacts are and then treated • children are vaccinated to protect them from TB. Unfortunately, no vaccine is available that provides reliable protection for adults

  21. Thank you

More Related